• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物转运蛋白的振荡、药物-膜物理相互作用和空间维度解释的耐药性“多态性”。

The "multi" of drug resistance explained by oscillating drug transporters, drug-membrane physical interactions and spatial dimensionality.

机构信息

School of Veterinary Medicine and Science, Sutton Bonington Campus, Sutton Bonington, University of Nottingham, Leicestershire LE12 5RD, UK.

出版信息

Cell Biochem Biophys. 2011 Sep;61(1):103-13. doi: 10.1007/s12013-011-9166-8.

DOI:10.1007/s12013-011-9166-8
PMID:21336588
Abstract

Multi-drug resistance (MDR) can be explained by a drug handling-type activity. In this context it is also necessary to consider the multi-specificity between drugs and drug transporters in order to explain MDR. Accordingly, the efficiency of drug efflux in MDR has always been a conceptual problem in biochemistry. Indeed, how one protein can expel, from cells, hundreds of compounds with high specificity is still controversial today. To safeguard the notion of biochemical specificity, many studies have suggested alternative mechanisms to Pgp-mediated drug resistance, which do not involve the handling of drugs. However, none of these studies have definitively ruled out the possibility concept of drug handling. Thus, until now it was not possible to imagine MDR without drug-transporter affinity or specificity. However, drug-transporter affinity is not always needed to generate what appears to be a very efficient chemical reaction. Indeed, based on the fact that bi-dimensional diffusion properties (i.e. diffusion in the membrane) are paramount to explain drug pumping-mediated MDR, it is possible to suggest how specific mathematical properties of random motions can be used to construct a model of Pgp-MDR, providing that Pgp oscillates between open/drug-accepting and closed/drug-expelling conformations. This different viewpoint highlights the fact that the multi-specificity of drug transporters and the "vacuum cleaner" hypothesis may actually be two sides of the same coin, both explained by the diffusion properties of drugs in the membrane. After retrieving basic results, predictions will be highlighted. Finally, the coherence of this model in the context of cancer biology will be discussed further.

摘要

多药耐药性 (MDR) 可以用药物处理型活性来解释。在这种情况下,还需要考虑药物和药物转运体之间的多特异性,以解释 MDR。因此,MDR 中药物外排的效率一直是生物化学中的一个概念问题。事实上,一种蛋白质如何能够从细胞中排出具有高度特异性的数百种化合物,今天仍然存在争议。为了维护生化特异性的概念,许多研究提出了替代 Pgp 介导的耐药性的机制,这些机制不涉及药物的处理。然而,这些研究都没有明确排除药物处理的概念。因此,到目前为止,人们还不可能想象没有药物转运体亲和力或特异性的 MDR。然而,产生似乎非常有效的化学反应并不总是需要药物转运体的亲和力。事实上,基于二维扩散特性(即膜内扩散)对于解释药物泵介导的 MDR 至关重要的事实,可以提出如何利用随机运动的特定数学特性来构建 Pgp-MDR 的模型,前提是 Pgp 在开放/药物接受和关闭/药物排出构象之间振荡。这种不同的观点强调了这样一个事实,即药物转运体的多特异性和“吸尘器”假说实际上可能是同一枚硬币的两面,都可以用药物在膜中的扩散特性来解释。在检索到基本结果后,将突出显示预测。最后,将进一步讨论该模型在癌症生物学背景下的一致性。

相似文献

1
The "multi" of drug resistance explained by oscillating drug transporters, drug-membrane physical interactions and spatial dimensionality.药物转运蛋白的振荡、药物-膜物理相互作用和空间维度解释的耐药性“多态性”。
Cell Biochem Biophys. 2011 Sep;61(1):103-13. doi: 10.1007/s12013-011-9166-8.
2
(+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells.(±)-3'-O,4'-O-二肉桂酰基-顺式凯拉内酯,(±)-前胡素A的衍生物,可逆转P-糖蛋白介导的癌细胞多药耐药性。
Bioorg Med Chem. 2006 Nov 1;14(21):7138-45. doi: 10.1016/j.bmc.2006.06.066. Epub 2006 Jul 27.
3
Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.通过加速药物被动跨质膜渗透来调节P-糖蛋白介导的多药耐药性。
FEBS J. 2007 Dec;274(23):6204-14. doi: 10.1111/j.1742-4658.2007.06140.x. Epub 2007 Nov 6.
4
Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.P-糖蛋白抑制剂对转染野生型(G185)或突变型(V185)多药转运体的NIH3T3细胞的不同作用。
Cancer Res. 1995 Mar 1;55(5):1086-91.
5
Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport.P-糖蛋白多药外排泵与胆固醇的相互作用:对ATP酶活性、药物结合及转运的影响。
Biochemistry. 2008 Dec 23;47(51):13686-98. doi: 10.1021/bi801409r.
6
Can long range mechanical interaction between drugs and membrane proteins define the notion of molecular promiscuity? Application to P-glycoprotein-mediated multidrug resistance (MDR).药物与膜蛋白之间的远程机械相互作用能否定义分子混杂性的概念?应用于P-糖蛋白介导的多药耐药性(MDR)。
Biochim Biophys Acta. 2013 Nov;1830(11):5112-8. doi: 10.1016/j.bbagen.2013.06.038. Epub 2013 Jul 10.
7
Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.多药耐药性:实体瘤中的临床相关性及规避策略
Curr Opin Oncol. 1998 Aug;10 Suppl 1:S15-9.
8
P-glycoprotein, multidrug resistance and protein kinase C.P-糖蛋白、多药耐药性与蛋白激酶C
Stem Cells. 1996 Jan;14(1):47-55. doi: 10.1002/stem.140047.
9
Mechanisms of chemotherapeutic drug resistance in cancer therapy--a quick review.癌症治疗中化疗耐药的机制——简要综述
Taiwan J Obstet Gynecol. 2009 Sep;48(3):239-44. doi: 10.1016/S1028-4559(09)60296-5.
10
Downregulation of JNK/SAPK activity is associated with the cross-resistance to P-glycoprotein-unrelated drugs in multidrug-resistant FM3A/M cells overexpressing P-glycoprotein.JNK/SAPK活性的下调与过表达P-糖蛋白的多药耐药FM3A/M细胞中对P-糖蛋白非相关药物的交叉耐药相关。
Exp Cell Res. 2000 Apr 10;256(1):300-7. doi: 10.1006/excr.2000.4807.

引用本文的文献

1
Cadmium transport by mammalian ATP-binding cassette transporters.金属镉通过哺乳动物 ATP 结合盒转运蛋白的转运。
Biometals. 2024 Jun;37(3):697-719. doi: 10.1007/s10534-024-00582-5. Epub 2024 Feb 6.
2
Teaching an old dog new tricks: reactivated developmental signaling pathways regulate ABCB1 and chemoresistance in cancer.老狗学新招:重新激活的发育信号通路调控癌症中的ABCB1及化疗耐药性
Cancer Drug Resist. 2021 Jun 19;4(2):424-452. doi: 10.20517/cdr.2020.114. eCollection 2021.
3
Sphingolipid abnormalities in cancer multidrug resistance: Chicken or egg?
癌症多药耐药中的鞘脂异常:鸡先有还是蛋先有?
Cell Signal. 2017 Oct;38:134-145. doi: 10.1016/j.cellsig.2017.06.017. Epub 2017 Jul 4.
4
Structural basis of RND-type multidrug exporters.RND型多药外排转运蛋白的结构基础
Front Microbiol. 2015 Apr 20;6:327. doi: 10.3389/fmicb.2015.00327. eCollection 2015.
5
Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.细胞膜表面压力差异在不表达 Pgp 和 ABCG2 的多柔比星耐药细胞中的重要性。
Cell Biochem Biophys. 2013 Jul;66(3):499-512. doi: 10.1007/s12013-012-9497-0.